FILTER

FILTERED INTERVIEW RESULTS

Martin van Gemert

REGIONAL VICE PRESIDENT (AFRICA), MINCON
"A big change that is shaping the mining value chain in Africa is the proliferation of mining contractors and, specifically, local contractors, which we believe will bring enormous socioeconomic benefits."

Nishen Hariparsad

GENERAL MANAGER (TECHNOLOGY, INNOVATION, GLOBAL PRODUCT MANAGEMENT MARKETING), BME
"While there remains a place for the more traditional blasting methods – with their characteristic limitations – the Global trend is very much towards advanced blasting solutions."

Hadley Natus

CHAIRMAN, TANTALEX LITHIUM RESOURCES CORP
Tantalex Lithium Resources updates GBR on its various projects in DRC.

Errol Smart

CEO, ORION MINERALS
Orion Minerals outlines its strategy for developing copper and zinc projects in South Africa.

Catherine Warburton

MANAGING DIRECTOR, WARBURTON ATTORNEYS INC
"The firm specializes in the dynamic field of sustainability law, focusing on environmental law, energy law, mining law and policy, and occupational and mine health and safety law."

Mark Bristow

PRESIDENT AND CEO, BARRICK GOLD
Mark Bristow spoke with GBR about Barrick’s global operations and sustainability philosophy.

Deon de Kock

PRESIDENT, SUB-SAHARAN AFRICA, MIDDLE EAST & SOUTH ASIA, FLSMIDTH
FLSmidth is an international supplier of sustainable solutions and services to the global cement and mining industries.

Mxolisi Mgojo, Nombasa Tsengwa & Sakkie Swanepoel

CEO; CEO-DESIGNATE AND MANAGING DIRECTOR OF MINERALS & GROUP MANAGER MARKETING, EXXARO RESOURCES
Exxaro considers the role of coal as South Africa moves towards green energies.

Cobus Loots

CEO, PAN AFRICAN RESOURCES
Pan African Resources is a mid-tier African-focused gold producer listed in Johannesburg and on the AIM market in London.

Freddy Mugeri

CEO, FABCHEM MINING
Fabchem is a leading OEM of strata control products.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

United States Life Sciences 2023

In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.

PARTNER EVENTS